Gentian Diagnostics ASA (OSL:GENT)

Norway · Delayed Price · Currency is NOK

38.10

+0.40 (1.06%)

Jun 4, 2026, 12:54 PM CET

Revenue by Segment

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals	176.50M	152.07M	135.15M	111.92M	100.01M
Pharmaceuticals Growth	16.07%	12.52%	20.76%	11.91%	26.78%
Total	176.50M	152.07M	135.15M	111.92M	100.01M
Total Growth	16.07%	12.52%	20.76%	11.91%	26.78%

Revenue by Geography

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Europe	114.18M	116.17M	92.76M	71.57M	55.68M
Europe Growth	-1.71%	25.24%	29.60%	28.55%	22.59%
Asia	32.88M	23.72M	33.67M	23.61M	25.01M
Asia Growth	38.64%	-29.57%	42.63%	-5.59%	67.74%
USA	29.44M	12.19M	8.72M	6.46M	2.44M
USA Growth	141.56%	39.72%	35.10%	164.81%	-18.79%
Total	176.50M	152.07M	135.15M	101.64M	83.12M
Total Growth	16.06%	12.52%	32.98%	22.27%	31.26%

Source: S&P Global Market Intelligence.